Back to News
Market Impact: 0.15
Dyno Therapeutics to Present New AAV Capsid Data Across Three Posters at the 33rd Annual Congress of the European Society of Gene & Cell Therapy
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
Dyno Therapeutics said it will present new AAV capsid data in three posters at the 33rd Annual Congress of the European Society of Gene & Cell Therapy. The article provides no results, financial figures, or further details about the data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- VCs will make billions on Anthropic’s IPO, but Amazon is set to make much (much) more
- Indian investors rush to Nvidia, SpaceX, Apple as local trading apps roll out access to U.S. stocks
- SK Hynix Q3 profit jumps more than 7-fold, beats forecasts
- Ultra Clean Holdings soars 11% on strong Q3 beat, upbeat outlook
- Meta Boosts Equity Offering to $98 Billion, Raising Its AI Bet